Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL738381

O=C(O)C(F)(F)F.OC1(c2ccc(F)cc2)CCN(c2ccc(OCCCN3CCCCC3)cc2)CC1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 10/20 0.61
HTR1A P08908 4/20 0.60
DRD2 P14416 4/20 0.60
HTR2A P28223 4/20 0.60
DRD3 P35462 4/20 0.60
HRH1 P35367 3/20 0.60
DRD1 P21728 2/20 0.60
DRD5 P21918 2/20 0.60
SLC6A2 P23975 1/20 0.60
SLC6A4 P31645 1/20 0.60
HTR7 P34969 1/20 0.60
HTR2B P41595 1/20 0.60
KCNH2 Q12809 3/20 0.55
TMEM97 Q5BJF2 2/20 0.53
SIGMAR1 Q99720 2/20 0.53
CYP3A4 P08684 1/20 0.49
MEN1 O00255 2/20 0.49
LMNA P02545 2/20 0.49
KMT2A Q03164 2/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL737443 0.91 HRH3 (0.60) HRH3HTR1ADRD2HTR2ADRD3
SCHEMBL738382 0.85 HRH3 (0.53) HRH3HTR1ADRD2HTR2ADRD3
SCHEMBL738421 0.85 HRH3 (0.70) HRH3HTR1ADRD2HTR2ADRD3
Trifluoroacetic Acid SCHEMBL736504 0.84 HRH3 (0.51) HRH3HRH1KCNH2ALDH1A1
Trifluoroacetic Acid SCHEMBL735635 0.84 HRH3 (0.57) HRH3HRH1KCNH2ALDH1A1
Trifluoroacetic Acid SCHEMBL735794 0.84 ALDH1A1 (0.56) HRH3SLC6A4KCNH2MEN1LMNA
Trifluoroacetic Acid SCHEMBL736519 0.83 HRH3 (0.55) HRH3HRH1KCNH2ALDH1A1
Trifluoroacetic Acid SCHEMBL738424 0.80 HRH3 (0.52) HRH3HRH1KCNH2ALDH1A1
Trifluoroacetic Acid SCHEMBL737082 0.80 HRH3 (0.47) HRH3HTR1ADRD2HTR2ADRD3
Hydrochloric Acid SCHEMBL11840393 0.80 DRD2 (0.86) HRH3HTR1ADRD2HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138206-B2 Piperidine derivative MSD. K.K. (JP) 2012-03-20 US claimed
US-20090137576-A1 Novel Piperidine Derivative MSD K.K. (JP) 2009-05-28 US claimed
EP-1892241-A1 NOVEL PIPERIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-02-27 EP claimed
US-8138206-B2 Piperidine derivative MSD. K.K. (JP) 2012-03-20 US disclosed
US-20090137576-A1 Novel Piperidine Derivative MSD K.K. (JP) 2009-05-28 US disclosed
EP-1892241-A1 NOVEL PIPERIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137576-A1 Novel Piperidine Derivative HRH4, HRH3, HRH1 HRH3 2/4885HTR1A 79/4885DRD2 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.